Cargando…
Recent advances in managing triple-negative breast cancers
Triple-negative breast cancer (TNBC) has been recently recognized as an important subgroup of breast cancer with a distinct outcome and therapeutic approach compared with other breast cancer subgroups. Because TNBC is defined by the absence of a target (either hormone receptors or HER-2), convention...
Autor principal: | Bengala, Carmelo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948296/ https://www.ncbi.nlm.nih.gov/pubmed/20948704 http://dx.doi.org/10.3410/M1-75 |
Ejemplares similares
-
Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
por: Pradhan, Rajesh, et al.
Publicado: (2023) -
Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019) -
Recent advances in nanotheranostics for triple negative breast cancer treatment
por: Thakur, Vikram, et al.
Publicado: (2019) -
Recent advances in therapeutic strategies for triple-negative breast cancer
por: Li, Yun, et al.
Publicado: (2022) -
Recent advances in targeted strategies for triple-negative breast cancer
por: Zhu, Shuangli, et al.
Publicado: (2023)